Analogic Co. (ALOG) Shares Sold by JPMorgan Chase & Co.

JPMorgan Chase & Co. reduced its stake in shares of Analogic Co. (NASDAQ:ALOG) by 39.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,992 shares of the medical research company’s stock after selling 3,834 shares during the quarter. JPMorgan Chase & Co.’s holdings in Analogic were worth $503,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Citadel Advisors LLC lifted its holdings in Analogic by 88.8% in the second quarter. Citadel Advisors LLC now owns 128,879 shares of the medical research company’s stock valued at $9,363,000 after buying an additional 60,614 shares during the period. Vanguard Group Inc. lifted its holdings in Analogic by 3.1% in the second quarter. Vanguard Group Inc. now owns 1,147,408 shares of the medical research company’s stock valued at $83,359,000 after buying an additional 34,765 shares during the period. TIAA CREF Investment Management LLC lifted its holdings in Analogic by 33.1% in the second quarter. TIAA CREF Investment Management LLC now owns 56,358 shares of the medical research company’s stock valued at $4,094,000 after buying an additional 14,022 shares during the period. Koch Industries Inc. lifted its holdings in Analogic by 8,505.7% in the second quarter. Koch Industries Inc. now owns 321,335 shares of the medical research company’s stock valued at $317,000 after buying an additional 317,601 shares during the period. Finally, Legal & General Group Plc lifted its holdings in Analogic by 7.7% in the second quarter. Legal & General Group Plc now owns 23,749 shares of the medical research company’s stock valued at $1,725,000 after buying an additional 1,696 shares during the period. 97.68% of the stock is currently owned by institutional investors and hedge funds.

Analogic Co. (ALOG) opened at $83.95 on Wednesday. Analogic Co. has a twelve month low of $66.00 and a twelve month high of $89.50. The firm has a market cap of $1,053.71, a P/E ratio of -14.68, a P/E/G ratio of 4.22 and a beta of 0.86.

Analogic (NASDAQ:ALOG) last announced its quarterly earnings data on Wednesday, December 6th. The medical research company reported $0.75 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.43 by $0.32. The business had revenue of $106.90 million for the quarter, compared to analyst estimates of $100.55 million. Analogic had a negative net margin of 15.06% and a positive return on equity of 5.09%. Analogic’s revenue was down 11.7% compared to the same quarter last year. During the same period in the prior year, the business posted $0.43 earnings per share. equities research analysts forecast that Analogic Co. will post 2.86 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Friday, December 29th. Shareholders of record on Friday, December 15th were issued a $0.10 dividend. The ex-dividend date of this dividend was Thursday, December 14th. This represents a $0.40 annualized dividend and a yield of 0.48%. Analogic’s dividend payout ratio (DPR) is presently -6.99%.

Several equities analysts recently weighed in on the stock. BidaskClub lowered shares of Analogic from a “sell” rating to a “strong sell” rating in a report on Saturday, January 6th. Jefferies Group restated a “hold” rating and issued a $80.00 price objective on shares of Analogic in a report on Friday, December 8th. Finally, Zacks Investment Research upgraded shares of Analogic from a “hold” rating to a “buy” rating and set a $97.00 price objective on the stock in a report on Friday, December 8th.

ILLEGAL ACTIVITY WARNING: “Analogic Co. (ALOG) Shares Sold by JPMorgan Chase & Co.” was posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this story on another website, it was stolen and republished in violation of United States & international copyright & trademark legislation. The correct version of this story can be accessed at https://stocknewstimes.com/2018/01/17/analogic-co-alog-shares-sold-by-jpmorgan-chase-co.html.

About Analogic

Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.

Want to see what other hedge funds are holding ALOG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Analogic Co. (NASDAQ:ALOG).

Institutional Ownership by Quarter for Analogic (NASDAQ:ALOG)

Receive News & Ratings for Analogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply